Search Results for lupus

Product: Dapttin® TC, 20x10ml

Product: Dapttin® TC, 2x10ml

Product: Dapttin® TC, 5x2ml

Product: Dapttin® TC, 6x10ml

Product: DiaPharma Factor X

Product: Ecarin 50-B

Product: Haematex dRVT LR

Product: Haematex dRVT LS

Product: Haematex Intrinsin LR APTT Reagent

Product: Haematex Intrinsin LS APTT Reagent

Product: REAADS Anti-Beta2 Glycoprotein I (Aβ2GPI) IgA

Product: REAADS Anti-Beta2 Glycoprotein I (Aβ2GPI) IgG

Product: REAADS Anti-Beta2 Glycoprotein I (Aβ2GPI) IgM

Product: REAADS Anti-Cardiolipin (aCL) IgA

Product: REAADS Anti-Cardiolipin (aCL) IgA

Product: REAADS Anti-Cardiolipin (aCL) IgG

Product: REAADS Anti-Cardiolipin (aCL) IgG/IgM

Product: REAADS Anti-Cardiolipin (aCL) IgG/IgM

Product: REAADS Anti-Cardiolipin (aCL) IgM

Product: Technoclone Lupus Anticoagulant Test

Product: Technoclone Lupus Inhibitor Plasma Low

Product: Technoclone Lupus Inhibitor Plasma, 2x1ml

Product: Technoclone Lupus Inhibitor Plasma, 5x1ml

Product: Technoclone Siron LIS (aPTT liquid), 10x10ml

Product: Technoclone Siron LIS (aPTT liquid), 10x4ml

Product: Technoclone Siron LIS (aPTT liquid), 2x4ml

Product: Technoclone Siron LS (aPTT liquid), 10x10ml

Product: Technoclone Siron LS (aPTT liquid), 10x4ml

Product: Technoclone Siron LS (aPTT liquid), 2x4ml

Product: Technoclot® LA (Lupus Anticoagulant) Confirm

Product: Technoclot® LA (Lupus Anticoagulant) Screen

Page: A Review of the XXXVth International Symposium on Technical Innovations in Laboratory Hematology 2023 (ISLH 2023)

Page: Activated partial thromboplastin time (aPTT)

Page: Activated Protein C (APC) and Factor V Leiden

Page: Antiphospholipid Antibodies

Page: CHOOSING WISELY - Coagulation Testing Recommendations

Page: CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY

Page: Clot Club

Page: Clot Club - Here The Clot Thickens

Page: Factor VIII (FVIII)

Page: Factor X (FX)

Page: Factor XI (FXI)

Page: Factor XII (FXII)

Page: Haematex

Page: Heparin

Page: HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

Page: ISTH 2021

Page: Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome - Part 1

Page: Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome – Part 2

Page: Neutrophil Extracellular Traps

Page: Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

Page: The Chromogenic Factor X Assay (CFX)

Page: The Latest Research on Direct Oral Anticoagulant (DOAC) Interferences in Testing

Page: Thrombophilia

Page: THSNA 2022 Recap

Page: UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?

News: Are your patients getting the proper level of anticoagulation?

News: Celebrate 35 years of Technoclone and a Special Ceveron® s100 price

News: Celebrate with DiaPharma at THSNA 2022 and learn about Ceveron® s100

News: Clot Club #21

News: Clot Club #22

News: Diapharma announces partnership with Haematex

News: DOAC-Stop

News: International Society on Thrombosis and Haemostasis (ISTH) 64th Annual Scientific and Standardization Committee (SSC) Meeting

News: Visit DiaPharma at ISTH and Register to Win!

Faq: What is the DiaPharma Factor X kit?

Faq: What is the normal baseline range for the APTT reaction? What types of conditions might cause a patient to give abnormal aPT time, and what can be done about it?

Faq: What is the role of Beta 2 Glycoprotein 1 (B2GP1) in anti-phospholipid antibody binding?

Faq: What is the utility of the DiaPharma Factor X kit? Am I expected to use this on ALL my Coumadin patients?

Faq: Why can't I just use a FX clotting assay?